COVID-19 Clinical Trials in New York, New York
8 recruitingNew York, New York
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
COVID-19Corona Virus Infection
Columbia University800 enrolled1 locationNCT04448145
Recruiting
Not Applicable
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Post-Acute COVID-19 SyndromeLong COVIDLong Covid19+3 more
Columbia University400 enrolled1 locationNCT07140094
Recruiting
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
COVID-19
NYU Langone Health350 enrolled1 locationNCT05292274
Recruiting
Phase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Pfizer160 enrolled73 locationsNCT05261139
Recruiting
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
COVID-19
Columbia University1,000 enrolled1 locationNCT05467930
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707